Bone marrow transplantation involves transplantation of hematopoietic stem cells or those stem cells that give rise to other types of blood cells. In such cases, age of the donor is important as younger donor age results in better outcome. A group of Indian scientists have now developed a mechanism that can rejuvenate stem cells from older donors, making them useful for transplantation.
The mechanism developed by researchers at the National Centre for Cell Science, Pune involves rejuvenating aged hematopoietic stem cells in a short-term culture using micro-vesicles secreted by young stromal cells. This approach, they hope, will expand donor cohort.
The finding has relevance in clinical bone marrow transplantation, wherein usually aged donors are not preferred as their stem cells could have compromised engraftment ability due to aging. With the new mechanism it might be possible to rejuvenate aged stem cells and thereby expand donor pool.
“Stromal cells are support cells present in the micro-environment of stem cells,” explained Dr Vaijayanti P Kale, who led the research team. “We have shown that these cells display activated AKT signalling as they age. This leads to a loss of autophagy-inducing mRNAs in their micro-vesicles. If this signalling is blocked by using chemical inhibitors in aged stromal cells in culture, they become ‘young-like’ and secrete good quality micro-vesicles containing autophagy-inducing mRNA that can rejuvenate aged stem cells.”
The findings have been published in scientific journal Stem Cells.
For the study, researchers used 6‐8 weeks (young) and 18‐24 months (aged) old mice because age‐associated changes in human hematopoietic stem cells are similar to those observed in mouse, suggesting that hematopoietic aging is an evolutionarily conserved process. Their bone marrow derived lineage-negative cells were treated with extracellular vesicles, micro-vesicles or exosomes isolated from conditioned medium of mesenchymal stromal cells for 36 hours. The output cells were subjected to phenotypic, functional and molecular characterizations. They observed that young mesenchymal stromal cells rejuvenate aged hematopoietic stem cells.
“Our data indicates that such rejuvenation may also be possible for other tissue-specific stem cells. We propose to extend our research towards stem cells from other tissues,” said Kale. She also added that this research has the potential to improve the outcome of regenerative medicine therapies using this approach.
The research team included Rohan Kulkarni, Manmohan Bajaj, Suprita Ghode, Sapana Jalnapurkar and Dr Lalita Limaye.
This article was first published by India Science Wire.
